The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Constrictive pericarditis - Pericardial thickening
Publications
An unusual side-effect of long-term methysergide treatment.
Australian and New Zealand journal of medicine 1995 Apr;25;171 — 1995 Apr — 171
Simulation of acute myopericarditis by constrictive pericardial disease with endomyocardial fibrosis due to methysergide therapy.
Journal of the American College of Cardiology 1984 Jul;4;196-9 — 1984 Jul — 196-9
Fibrotic disorders associated with methysergide therapy for headache.
The New England journal of medicine 1966 Feb 17;274;359-68 — 1966 Feb 17 — 359-68
Constrictive pericarditis due to methysergide therapy.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 1976 Sep 25;50;1595-7 — 1976 Sep 25 — 1595-7
Methysergide therapy and constrictive pericarditis.
Annals of internal medicine 1978 Feb;88;213-4 — 1978 Feb — 213-4